JP2023524995A5 - - Google Patents

Info

Publication number
JP2023524995A5
JP2023524995A5 JP2022567339A JP2022567339A JP2023524995A5 JP 2023524995 A5 JP2023524995 A5 JP 2023524995A5 JP 2022567339 A JP2022567339 A JP 2022567339A JP 2022567339 A JP2022567339 A JP 2022567339A JP 2023524995 A5 JP2023524995 A5 JP 2023524995A5
Authority
JP
Japan
Prior art keywords
canine
seq
amino acid
acid sequence
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022567339A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524995A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/030476 external-priority patent/WO2021225961A1/en
Publication of JP2023524995A publication Critical patent/JP2023524995A/ja
Publication of JP2023524995A5 publication Critical patent/JP2023524995A5/ja
Pending legal-status Critical Current

Links

JP2022567339A 2020-05-04 2021-05-03 イヌpd-1結合性ポリペプチド及びその使用 Pending JP2023524995A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063019817P 2020-05-04 2020-05-04
US63/019,817 2020-05-04
PCT/US2021/030476 WO2021225961A1 (en) 2020-05-04 2021-05-03 Canine pd-1-binding polypeptides and uses thereof

Publications (2)

Publication Number Publication Date
JP2023524995A JP2023524995A (ja) 2023-06-14
JP2023524995A5 true JP2023524995A5 (https=) 2024-05-15

Family

ID=76076497

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022567339A Pending JP2023524995A (ja) 2020-05-04 2021-05-03 イヌpd-1結合性ポリペプチド及びその使用

Country Status (10)

Country Link
US (1) US20230331846A1 (https=)
EP (1) EP4146696A1 (https=)
JP (1) JP2023524995A (https=)
KR (1) KR20230005955A (https=)
CN (1) CN115776990A (https=)
AU (1) AU2021266688A1 (https=)
BR (1) BR112022022352A2 (https=)
CA (1) CA3177921A1 (https=)
MX (1) MX2022013840A (https=)
WO (1) WO2021225961A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110982824B (zh) * 2019-10-09 2022-04-15 天津大学 拮抗pd-1的抗体类似物bp基因及蛋白和应用
JP2026508096A (ja) * 2023-01-20 2026-03-10 ゾエティス・サービシーズ・ユーケー・リミテッド 治療抗体
CN120137035A (zh) * 2023-12-06 2025-06-13 北京伟杰信生物科技有限公司 一种抗犬pd-1抗体及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US7217797B2 (en) 2002-10-15 2007-05-15 Pdl Biopharma, Inc. Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
CA2541651C (en) 2003-10-22 2011-05-24 Keck Graduate Institute Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
AU2012328819B2 (en) * 2011-10-26 2017-08-03 Elanco Tiergesundheit Ag Monoclonal antibodies and methods of use
CN106029697B (zh) * 2013-12-20 2021-06-04 英特维特国际股份有限公司 具有经修饰的ch2-ch3序列的犬抗体
US10280223B2 (en) * 2014-07-09 2019-05-07 Nippon Zenyaku Kogyo Co., Ltd. Anti-canine PD-1 antibody or anti-canine PD-L1 antibody
KR102357893B1 (ko) * 2014-08-05 2022-02-04 맵퀘스트 에스아 Pd-1 에 결합하는 면역학적 시약
CN107074952B (zh) * 2014-09-30 2021-04-09 英特维特国际股份有限公司 结合犬pd-l1的pd-l1抗体
CN120623346A (zh) * 2018-10-11 2025-09-12 因荷布瑞克斯生物科学公司 Pd-1单结构域抗体及其治疗组合物
CN110194799B (zh) * 2019-06-03 2021-07-23 北京希诺谷生物科技有限公司 结合犬pd-1的抗犬pd-1抗体

Similar Documents

Publication Publication Date Title
US11466085B2 (en) Anti-PD-L1 nanobody, coding sequence and use thereof
CN109942712B (zh) 抗pd-l1/vegf双功能抗体及其用途
US11292841B2 (en) Anti-PD-1 nano-antibody and application thereof
JP6824245B2 (ja) Dll3及びcd3に結合する二重特異性抗体構築物
US12168695B2 (en) Bispecific antibody for cancer immunotherapy
WO2018233574A1 (zh) 一种抗pd-l1人源化纳米抗体及其应用
KR20200066623A (ko) 인터류킨-18 변이체 및 사용 방법
KR20180075689A (ko) 키메라 항원 수용체에 관한 방법 및 조성물
JP2020529863A (ja) 抗ror1抗体とその作製及び使用方法
JP2018518540A (ja) 新規pd−1免疫調節剤
JP6242484B2 (ja) 特定の改善されたヒト二重特異性EGFRvIII抗体結合分子
TW201023863A (en) Antitumor combinations containing antibodies recognizing specifically CD38 and cytarabine
JP2018524997A (ja) Egfrviii及びcd3に結合する二重特異性抗体構築物
CZ20014083A3 (cs) Léčivo pro indikaci růstu refrakterních nádorů
EA030147B1 (ru) Биспецифические антигенсвязывающие молекулы, активирующие т-клетки
JP2020530306A (ja) 多重特異性抗体とその作製及び使用方法
JP2023524995A5 (https=)
JP6154895B2 (ja) ヒト二重特異性EGFRvIII抗体結合分子
KR20200092301A (ko) 다중-특이적 항체 및 이를 제조하는 방법 및 이의 용도
JP2022513421A5 (https=)
JP2020537690A (ja) プレクチン1結合抗体およびその使用
JP2022526194A (ja) Flt3特異的キメラ抗原受容体およびその使用方法
CN113980133B (zh) 抗体及其在抗肿瘤中的应用
CA3229251A1 (en) Interleukin-12 variants and methods of use
JP7054143B2 (ja) キメラ抗原受容体、及びその利用